Aspen Pharmacare Holdings (STU:LDZA) LT-Debt-to-Total-Asset: (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:LDZA Aspen Pharmacare Holdings Ltd STU:LDZA
72 GF Score
Price €8.15
GF Value €8.86
Valuation Fairly Valued
! 10 Warning Signs
View Full Analysis

What is Aspen Pharmacare Holdings LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Aspen Pharmacare Holdings's long-term debt to total assests ratio for the quarter that ended in Jun. 2026 was .

Aspen Pharmacare Holdings's long-term debt to total assets ratio declined from Jun. 2025 (0.23) to Jun. 2026 (). It may suggest that Aspen Pharmacare Holdings is progressively becoming less dependent on debt to grow their business.

Aspen Pharmacare Holdings  (STU:LDZA) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Aspen Pharmacare Holdings LT-Debt-to-Total-Asset Related Terms

Aspen Pharmacare Holdings LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Aspen Pharmacare Holdings's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aspen Pharmacare Holdings LT-Debt-to-Total-Asset Chart

Aspen Pharmacare Holdings Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.16 0.18 0.23

Aspen Pharmacare Holdings Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.18 0.23 0.23 0.23
STU:LDZA
72GF Score
Aspen Pharmacare Holdings Ltd STU:LDZA
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aspen Pharmacare Holdings LT-Debt-to-Total-Asset Calculation

Aspen Pharmacare Holdings's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jun. 2026 is calculated as

LT Debt to Total Assets (A: Jun. 2026 )=Long-Term Debt & Capital Lease Obligation (A: Jun. 2026 )/Total Assets (A: Jun. 2026 )
=506.812/5778.046
=0.09

Aspen Pharmacare Holdings's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jun. 2026 is calculated as

LT Debt to Total Assets (Q: Jun. 2026 )=Long-Term Debt & Capital Lease Obligation (Q: Jun. 2026 )/Total Assets (Q: Jun. 2026 )
=506.812/5778.046
=0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Aspen Pharmacare Holdings (STU:LDZA) Overvalued in 2026?

Based on GuruFocus' analysis, Aspen Pharmacare Holdings stock appears to be undervalued. The current stock price of €8.15 is trading 8% below its estimated GF Value™ of €8.86. GuruFocus considers Aspen Pharmacare Holdings to be Fairly Valued.

Key valuation signals for STU:LDZA:

  • LT-Debt-to-Total-Asset:
  • GF Value™: €8.86 vs. price of €8.15 (8% below fair value)
  • GF Score™: 72/100 with 10 warning signs

No single metric tells the full story. See the STU:LDZA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aspen Pharmacare Holdings Business Description

Address Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, La Lucia Ridge, Durban, NL, ZAF
Aspen Pharmacare Holdings Ltd is a multinational pharmaceutical company. The group focuses on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets. The business segments of the group are split between the Commercial Pharmaceuticals and Manufacturing segments. The Commercial Pharmaceuticals business segments are: Injectables, Over-the-counter, and Prescription. The Manufacturing business segments are: Active Pharmaceutical Ingredients, Finished Dose Form, and Heparin. Its geographic regions are Africa Middle East, Europe CIS, Australasia, Asia, and America.
72GF Score

Get the complete analysis for STU:LDZA

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.15
Price
€8.86
GF Value